|
VERV Verve Therapeutics Inc 1840574 |
| Balance Sheet |
|
Current Assets
|
556,459,000 |
|
Assets
|
663,906,000 |
|
Current Liabilities
|
42,642,000 |
|
Liabilities
|
155,355,000 |
|
Equity
|
508,551,000 |
|
Shares Out
|
84,625,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-116,847,000 |
|
Investing Cash Flow
|
45,330,000 |
| Market Analysis |
Market Cap
|
463,742,426 |
|
Price
|
6.14 |
|
BVPS
|
6.01 |
|
PB
|
1.03 |
|
EPS
|
-2.59 |
|
PS
|
3.15 |
|
FCF
|
-71,517,000 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view VERV documents filed with the SEC.
VERV Filings
Clear
